Search research articles
Contact Us
Filters
Showing results (261-270 of 377) with videos related to
Page
of 38
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2022
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
Harun Ilhan, Markus Kroenke, Alexander Wurzer, et al.
The Journal of Urology
|
March 12, 2016
Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer
Matthias M Heck, Margitta Retz, Calogero D'Alessandria, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2017
<sup>68</sup>Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer
Maria Vinsensia, Peter L Chyoke, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2020
Positive Predictive Value and Correct Detection Rate of <sup>18</sup>F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
Maythinee Chantadisai, Gabriel Buschner, Markus Krönke, et al.
Nuklearmedizin. Nuclear Medicine
|
March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Lale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
European Urology Oncology
|
May 27, 2020
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy
Kilian Schiller, Lucia Stöhrer, Mathias Düsberg, et al.
European Urology Oncology
|
April 7, 2024
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
Andrei Gafita, Andrew J Martin, Louise Emmett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First Experience Using <sup>18</sup>F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma
Lukas Kessler, Anna M Schlitter, Markus Krönke, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Lale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
Nuklearmedizin. Nuclear Medicine
|
June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]
Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
Page
of 38
Search research articles
Search
Showing results (261-270 of 377) with videos related to
Sort By:
Page
of 38
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 11, 2022
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
Harun Ilhan, Markus Kroenke, Alexander Wurzer, et al.
The Journal of Urology
|
March 12, 2016
Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer
Matthias M Heck, Margitta Retz, Calogero D'Alessandria, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 23, 2017
<sup>68</sup>Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer
Maria Vinsensia, Peter L Chyoke, Boris Hadaschik, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2020
Positive Predictive Value and Correct Detection Rate of <sup>18</sup>F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard
Maythinee Chantadisai, Gabriel Buschner, Markus Krönke, et al.
Nuklearmedizin. Nuclear Medicine
|
March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Lale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
European Urology Oncology
|
May 27, 2020
PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy
Kilian Schiller, Lucia Stöhrer, Mathias Düsberg, et al.
European Urology Oncology
|
April 7, 2024
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [<sup>177</sup>Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
Andrei Gafita, Andrew J Martin, Louise Emmett, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 30, 2020
First Experience Using <sup>18</sup>F-Flubrobenguane PET Imaging in Patients with Suspected Pheochromocytoma or Paraganglioma
Lukas Kessler, Anna M Schlitter, Markus Krönke, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
March 1, 2019
Whole-Body [18F]-FDG-PET/MRI for Oncology: A Consensus Recommendation
Lale Umutlu, Thomas Beyer, Johannes Stefan Grueneisen, et al.
Nuklearmedizin. Nuclear Medicine
|
June 17, 2020
[Structured reporting in oncologic hybrid imaging: a consensus recommendation]
Thorsten Derlin, Sergios Gatidis, Bernd Joachim Krause, et al.
Page
of 38